Ischemic preconditioning attenuates postischemic leukocyte-endothelial cell interactions - Role of nitric oxide and protein kinase C

Circulation Journal

Volumn 70, Issue 8, 2006, Pages 1070-1075

  Huang, Shiang Suo ^a   Wei, Fu Chan ^b   Hung, Li Man ^b,c  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Ischemia reperfusion; Ischemic preconditioning; Microcirculation; Nitric oxide synthase

Indexed keywords

CHELERYTHRINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; N(G) NITRO DEXTRO ARGININE METHYL ESTER; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CAPILLARY DENSITY; CELL INTERACTION; CONTROLLED STUDY; CREMASTER MUSCLE; DRUG INHIBITION; ENDOTHELIUM CELL; ENZYME INHIBITION; EPIGASTRIC ARTERY; GENE EXPRESSION; ISCHEMIA; ISCHEMIC PRECONDITIONING; LEUKOCYTE; LEUKOCYTE ADHERENCE; LEUKOCYTE MIGRATION; LEUKOCYTE ROLLING; MALE; MICROCIRCULATION; MICROSCOPY; MUSCLE CAPILLARY; NONHUMAN; RAT; REPERFUSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

ANIMALS; CELL ADHESION; CELL COMMUNICATION; CELL MOVEMENT; ENDOTHELIAL CELLS; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; ISCHEMIC PRECONDITIONING; LEUKOCYTES; MICROCIRCULATION; MUSCLE, SKELETAL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE I; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; PROTEIN KINASE C; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; RNA, MESSENGER; UP-REGULATION;

EID: 33746729503     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.70.1070     Document Type: Article

References (47)

1. Crinnion JN, Homer-Vanniasinkam S, Gough MJ. Skeletal muscle reperfusion injury: Pathophysiology and clinical considerations. Cardiovasc Surg 1993; 1: 317-324.
2. Carden DL, Granger DN. Pathophysiology of ischaemia reperfusion injury. J Pathol 2000; 190: 255-266.
3. Murry C, Jenning R, Reimer K. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74: 1124-1136.
4. Glazier SS, O'Rourke DM, Graham DI, Welsh FA. Induction of ischemic tolerance following brief focal ischemia in rat brain. J Cereb Blood Flow Metab 1994; 14: 545-553.
5. Pang CY, Yang RZ, Zhong A, Xu N, Boyd B, Forrest CR. Acute ischaemic preconditioning protects against skeletal muscle infarction in the pig. Cardiovasc Res 1995; 29: 782-788.
6. Hotter G, Closa D, Prados M, Fernandez-Cruz L, Prats N, Gelpi E, et al. Intestinal preconditioning is mediated by a transient increase in nitric oxide. Biochem Biophys Res Commun 1996; 222: 27-32.
7. Peralta C, Closa D, Hotter G, Gelpi E, Prats N, Rosello-Catafau J. Liver ischemic preconditioning is mediated by the inhibitory action of nitric oxide on endothelin. Biochem Biophys Res Commun 1996; 229: 264-270.
8. Peralta C, Hotter G, Closa D, Prats N, Xaus C, Gelpi E, et al. The protective role of adenosine in inducing nitric oxide synthesis in rat liver ischemia preconditioning is mediated by activation of adenosine A2 receptors. Hepatology 1999; 29: 126-132.
9. Moncada S, Palmer RM, Higger EA. Nitric oxide: Physiology, pathology, and pharmacology. Pharmacol Rev 1991; 43: 109-142.
10. Knowles RG, Moncada S. Nitric oxide synthases in mammals. Biochem J 1994; 298: 249-258.
11. Alderton WK, Cooper CE, Knowles RG. Nitric oxide synthases: Structure, function and inhibition. Biochem J 2001; 357: 593-615.
12. Radomski MW, Palmer RM, Moncada S. The anti-aggregating properties of vascular endothelium: Interactions between prostacyclin and nitric oxide. Br J Pharmacol 1987; 92: 639-646.
13. McGowan FX Jr, Davis PJ, del Nido PJ, Sobek M, Allen JW, Downing SE. Endothelium-dependent regulation of coronary tone in the neonatal pig. Anesth Analg 1994; 79: 1094-1101.
14. Kubes P, Suzuki M, Granger DN. Nitric oxide: An endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 1991; 88: 4651-4655.
15. Groves PH, Lewis MJ, Cheadle HA, Penny WJ. SIN-1 reduces platelet adhesion and platelet thrombus formation in a porcine model of balloon angioplasty. Circulation 1993; 87: 590-597.
16. Ping P, Takano H, Zhang J, Tang XL, Qiu Y, Li RC, et al. Isoform-selective activation of protein kinase C by nitric oxide in the heart of conscious rabbits: A signaling mechanism for both nitric oxide-induced and ischemia-induced preconditioning. Circ Res 1999; 84: 587-604.
17. Hung LM, Wei W, Hsueh YJ, Chu WK, Wei FC. Ischemic preconditioning ameliorates microcirculatory disturbance through downregulation of TNF-α production: Rat cremaster muscle model. J Biomed Sci 2004; 11: 773-780.
18. Cutrn JC, Perrelli MG, Cavalieri B, Peralta C, Rosell-Catafau J, Poli G. Microvascular dysfunction induced by reperfusion injury and protective effect of ischemic preconditioning. Free Radic Biol Med 2002; 33: 1200-1208.
19. Yellon DM, Baxter GF, Garcia-Dorado D, Heusch D, Sumeray MS. Ischaemic preconditioning: Present position and future directions. Cardiovasc Res 1998; 37: 21-33.
20. Ferdinandy P, Szilvassy S, Balogh N, Csonka C, Csont T, Koltai M, et al. Nitric oxide is involved in active preconditioning in isolated working rat hearts. Ann NY Acad Sci 1996; 793: 489-493.
21. Yao Z, Gross GJ. Acetylcholine mimics ischemic preconditioning via a glibenclamide-sensitive mechanism in dogs. Am J Physiol 1993; 264: H2221-H2225.
22. Nonomura M, Nozawa T, Matsuki A, Nakadate T, Igarashi N, Kato B, et al. Ischemia-induced norepinephrine release, but not norepinephrine-derived free radicals, contributes to myocardial ischemia-reperfusion injury. Circ J 2005; 69: 590-595.
23. Liu Y, Tsuchida A, Cohen MV, Downey JM. Pretreatment with angiotensin II activates protein kinase C and limits myocardial infarction in isolated rabbit hearts. J Mol Cell Cardiol 1995; 27: 883-892.
24. Baxter GF, Ebrahim Z. Role of bradykinin in preconditioning and protection of the ischaemic myocardium. Br J Pharmacol 2002; 135: 843-854.
25. Lim ST, Bae EH, Jeong MH, Kang DG, Lee YS, Lim KH, et al. Effect of combined intracoronary adenosine and nicorandil on no-reflow phenomenon during percutaneous coronary intervention. Cardiovasc J 2004; 68: 868-872.
26. Yaguchi Y, Satoh H, Wakahara N, Katoh H, Uehara A, Terada H, et al. Protective effects of hydrogen peroxide against ischemia/reperfusion injury in perfused rat hearts. Circ J 2003; 67: 253-258.
27. Chen W, Gabel S, Steenbergen C, Murphy E. A redox-based mechanism for cardioprotection induced by ischemic preconditioning in perfused rat heart. Circ Res 1995; 77: 424-429.
28. Zhou X, Zhai X, Ashraf M. Direct evidence that initial oxidative stress triggered by preconditioning contributes to second window of protection by endogenous antioxidant enzyme in myocytes. Circulation 1996; 93: 1177-1184.
29. Jerome SN, Akimitsu T, Gute DC, Korthuis RJ. Ischemic preconditioning attenuates capillary no-reflow induced by prolonged ischemia and reperfusion. Am J Physiol 1995; 268: H2063-H2067.
30. Richard V, Kaeffer N, Tron C, Thuillez C. Ischemic preconditioning protects against coronary endothelial dysfunction induced by ischemia and reperfusion. Circulation 1994; 89: 1254-1261.
31. Akimitsu T, Gute DC, Korthuis RJ. Ischemic preconditioning attenuates postischemic leukocyte adhesion and emigration. Am J Physiol 1996; 271: H2052-H2059.
32. Kubes P, Payne D, Ostrovsky L. Preconditioning and adenosine in I/R-induced leukocyte-endothelial cell interactions. Am J Physiol 1998; 274: H1230-H1238.
33. Colletti LM, Remick DG, Burtch GD, Kunkel SL, Strieter RM, Campbell DA Jr. Role of tumor necrosis factor-α in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat. J Clin Invest 1990; 85: 1936-1943.
34. Kitakaze M, Hori M, Morioka T, Minamino T, Takashima S, Sato H, et al. Alpha 1-adrenoceptor activation mediates the infarct size-limiting effect of ischemic preconditioning through augmentation of 5′-nucleotidase activity. J Clin Invest 1994; 93: 2197-2205.
35. Node K, Kitakaze M, Sato H, Minamino T, Komamura K, Shinozaki Y, et al. Role of intracellular Ca2+ in activation of protein kinase C during ischemic preconditioning. Circulation 1997; 96: 1257-1265.
36. Dawn B, Bolli R. Role of nitric oxide in myocardial preconditioning. Ann NY Acad Sci 2002; 962: 18-41.
37. Cohen MV, Yang XM, Liu GS, Heusch G, Downey JM. Acetylcholine, bradykinin, opioids, and phenylephrine, but not adenosine, trigger preconditioning by generating free radicals and opening mitochondrial K (ATP) channels. Circ Res 2001; 89: 273-278.
38. Wang WZ, Fang XH, Stepheson LL, Khiabani KT, Zamboni WA. NOS upregulation attenuates vascular endothelial dysfunction in the late phase of ischemic preconditioning in skeletal muscle. J Orthop Res 2004; 22: 578-585.
39. Tatchum-Talom R, Schulz R, McNeill JR, Khadour FH. Upregulation of neuronal nitric oxide synthase in skeletal muscle by swim training. Am J Physiol Heart Circ Physiol 2000; 279: H1757-H1766.
40. Abdelmoity A, Padre RC, Burzynski KE, Stull JT, Lau KS. Neuronal nitric oxide synthase localizes through multiple structural motifs to the sarcolemma in mouse myotubes. FEBS Lett 2000; 482: 65-70.
41. Banwait KS, Rattan S. Role of nitric oxide in beta-3-adrenoceptor activation on basal tone of internal anal sphincter. Am J Physiol Gastrointest Liver Physiol 2003; 285: G547-G555.
42. Qi WN, Chaiyakit P, Cai Y, Allen DM, Chen LE, Seaber AV, et al. NF-kappa-B p65 involves in reperfusion injury and iNOS gene regulation in skeletal muscle. Microsurgery 2004; 24: 316-323.
43. Elliott GT. Monophosphoryl lipid A induces delayed preconditioning against cardiac ischemia-reperfusion injury. J Mol Cell Cardiol 1998; 30: 3-17.
44. Mori E, Haramaki N, Ikeda H, Imaizumi T. Intra-coronary administration of L-arginine aggravates myocardial stunning through the production of peroxynitrite in dogs. Cardiovasc Res 1998; 40: 113-123.
45. Albrecht EW, Stegeman CA, Heeringa P, Henning RH, van Goor H. Protective role of endothelial nitric oxide synthase. J Pathol 2003; 199: 8-17.
46. Laude K, Favre J, Thuillez C, Richard V. NO produced by endothelial NO synthase is a mediator of delayed preconditioning-induced endothelial protection. Am J Physiol Heart Circ Phsiol 2003; 284: H2053-H2060.
47. Muscari C, Bonafe F, Gamberini C, Giordano E, Tantini B, Fattori M, et al. Early preconditioning prevents the loss of endothelial nitric oxide synthase and enhances its activity in the ischemic/reperfused rat heart. Life Sci 2004; 74: 1127-1137.